- £381.05m
- £375.52m
- £149.41m
- 29
- 76
- 72
- 64
Annual income statement for MHA, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 87.8 | 111 | 149 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 54.5 | 65.1 | 91.3 |
| Operating Profit | 33.3 | 45.7 | 58.1 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 32.3 | 44.9 | 58.2 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 31.7 | 44 | 56.3 |
| Net Income Before Extraordinary Items | |||
| Net Income | 31.7 | 44 | 56.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 31.7 | 44 | 56.3 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 0.117 | 0.163 | 0.208 |
| Dividends per Share |